A detailed history of Taikang Asset Management (Hong Kong) CO LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Taikang Asset Management (Hong Kong) CO LTD holds 500 shares of LLY stock, worth $442,775. This represents 0.07% of its overall portfolio holdings.

Number of Shares
500
Holding current value
$442,775
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $362,435 - $454,520
500 New
500 $452,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $841B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Taikang Asset Management (Hong Kong) CO LTD Portfolio

Follow Taikang Asset Management (Hong Kong) CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taikang Asset Management (Hong Kong) CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Taikang Asset Management (Hong Kong) CO LTD with notifications on news.